A detailed history of Creative Planning transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Creative Planning holds 10,540 shares of TNDM stock, worth $329,058. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,540
Previous 11,935 11.69%
Holding current value
$329,058
Previous $480,000 7.08%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$35.21 - $47.3 $49,117 - $65,983
-1,395 Reduced 11.69%
10,540 $446,000
Q2 2024

Aug 15, 2024

BUY
$30.43 - $53.43 $105,318 - $184,921
3,461 Added 40.84%
11,935 $480,000
Q1 2024

May 10, 2024

BUY
$22.09 - $35.41 $14,800 - $23,724
670 Added 8.59%
8,474 $300,000
Q4 2023

Feb 14, 2024

BUY
$14.28 - $31.03 $109,656 - $238,279
7,679 Added 6143.2%
7,804 $230,000
Q3 2023

Nov 16, 2023

BUY
$19.33 - $36.22 $2,416 - $4,527
125 New
125 $2,000
Q1 2023

May 15, 2023

SELL
$35.86 - $46.5 $38,908 - $50,452
-1,085 Reduced 16.02%
5,687 $230,000
Q4 2022

Feb 10, 2023

BUY
$35.49 - $56.15 $45,782 - $72,433
1,290 Added 23.53%
6,772 $304,000
Q3 2022

Nov 03, 2022

BUY
$43.76 - $68.97 $56,756 - $89,454
1,297 Added 30.99%
5,482 $262,000
Q2 2022

Aug 15, 2022

BUY
$53.22 - $123.09 $41,085 - $95,025
772 Added 22.62%
4,185 $248,000
Q1 2022

May 16, 2022

BUY
$101.89 - $150.09 $41,265 - $60,786
405 Added 13.46%
3,413 $397,000
Q4 2021

Feb 11, 2022

SELL
$118.18 - $153.21 $19,263 - $24,973
-163 Reduced 5.14%
3,008 $453,000
Q2 2021

Aug 04, 2021

BUY
$77.0 - $100.19 $244,167 - $317,702
3,171 New
3,171 $309,000
Q2 2020

Jul 23, 2020

SELL
$60.05 - $98.92 $383,058 - $631,010
-6,379 Closed
0 $0
Q1 2020

May 05, 2020

SELL
$47.37 - $90.04 $528,175 - $1 Million
-11,150 Reduced 63.61%
6,379 $410,000
Q4 2019

Jan 30, 2020

SELL
$53.13 - $71.19 $5,578 - $7,474
-105 Reduced 0.6%
17,529 $1.05 Million
Q3 2019

Nov 01, 2019

SELL
$57.11 - $73.3 $78,983 - $101,373
-1,383 Reduced 7.27%
17,634 $1.04 Million
Q2 2019

Jul 26, 2019

BUY
$54.41 - $71.7 $39,991 - $52,699
735 Added 4.02%
19,017 $1.23 Million
Q1 2019

Apr 24, 2019

SELL
$32.25 - $73.56 $165,990 - $378,613
-5,147 Reduced 21.97%
18,282 $1.16 Million
Q4 2018

Feb 01, 2019

SELL
$28.45 - $40.65 $48,365 - $69,105
-1,700 Reduced 6.77%
23,429 $890,000
Q3 2018

Oct 25, 2018

BUY
$21.39 - $51.17 $88,319 - $211,280
4,129 Added 19.66%
25,129 $1.08 Million
Q2 2018

Jul 20, 2018

SELL
$4.9 - $23.64 $24,500 - $118,200
-5,000 Reduced 19.23%
21,000 $462,000
Q1 2018

Apr 18, 2018

BUY
$2.35 - $4.96 $18,800 - $39,680
8,000 Added 44.44%
26,000 $129,000
Q4 2017

Jan 17, 2018

BUY
$2.24 - $8.2 $40,320 - $147,600
18,000
18,000 $42,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.